Cooley-Led Biotech Firm Leads 4 IPOs Totaling $847M

Retrieved on: 2021-06-17 20:48:45

Tags for this article:

Click the tags to see associated articles and topics

Cooley-Led Biotech Firm Leads 4 IPOs Totaling $847M. View article details on hiswai:

Excerpt

Gene-editing biotechnology firm Verve Therapeutics Inc., advised by WilmerHale, sold more than 14 million shares at $19 each, raising $267 million in ...

Article found on: www.law360.com

View Original Article